肿瘤药学Issue(1)：71-75,5.DOI:10.3969/j.issn.2095-1264.2014.015
大剂量131I 治疗致分化型甲状腺癌患者睡眠障碍的原因分析及护理体会
Analysis of the cause of High Doses of 131 Iodine Treatment Induced Sleep Disorders in Patients with Differentiated Thyroid Cancer and Nursing Experience
易于颦 1朱玉泉 1闫亚云 1胡凤琼1
作者信息
- 1. 重庆医科大学附属第一医院 核医学科，重庆，400016
- 折叠
摘要
Abstract
Objective To investigate the possible cause of the sleep disorders of patients with differentiated thyroid cancer after high-dose therapeutic 131I administration and to explore care measures that may improve the sleep quality of those patients. Methods 106 patients with differentiated thyroid cancer treated with high-dose 131 Iodine were randomly and equally divided into intervention and control group. The control group was given routine nursing whereas intervention group received extra nurs-ing intervention in addition to the same routine care as the control group. The Pittsburgh Sleep Quality Index (PSQI) scale was adapted for rating sleep quality and a self-designed questionnaire was used for the analysis of factors may contribute to sleep disorders. Results Our data show that there are significant differences between intervention comparison and control group on discharge (P≤0.05). The main factors affecting sleep are psychological (pessimism over cancer, concerns about prognosis, fear of radioactive therapy, isolation during treatment, etc.), physiological (pain of neck wound, hypothyroidism and side effects of radioactive therapy) or environmental. Conclusion Thyroid cancer patients received high-dose 131 Iodine treatment usually have sleep problems caused by various factors. We should take relevant measures to relieve physical discomforts and negative emo-tions from them and enhance their knowledge about prognosis and radiotherapy in particular; thus we could improve sleep qual-ity of the patients.关键词
131I/分化型甲状腺癌/睡眠质量/护理Key words
High-dose 131 Iodine treatment/Thyroid cancer/Sleep quality/Nursing care分类
医药卫生引用本文复制引用
易于颦,朱玉泉,闫亚云,胡凤琼..大剂量131I 治疗致分化型甲状腺癌患者睡眠障碍的原因分析及护理体会[J].肿瘤药学,2014,(1):71-75,5.
